Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-12 Sale |
2024-02-12 4:35 pm |
ImmunoGen Inc. | IMGN | VASCONCELLES MICHAEL EVP R&D & MEDICAL AFFAIRS |
1,327 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-09-13 Option Award |
2024-09-17 4:10 pm |
N/A 2034-09-12 |
Kura Oncology Inc. | KURA | VASCONCELLES MICHAEL Director |
69,333 | $0 | 69,333 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 9:29 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | VASCONCELLES MICHAEL EVP R&D & MEDICAL AFFAIRS |
50,515 | $0 | 50,515 (Direct) |
View |
| 2023-12-29 Option Award |
2024-01-03 5:48 pm |
N/A N/A |
ImmunoGen Inc. | IMGN | VASCONCELLES MICHAEL EVP R&D & MEDICAL AFFAIRS |
1,327 | $16.01 | 1,327 (Direct) |
View |
| 2022-12-29 Option Award |
2023-01-03 5:17 pm |
N/A 2032-12-29 |
ImmunoGen Inc. | IMGN | VASCONCELLES MICHAEL EVP R&D & MEDICAL AFFAIRS |
960,000 | $0 | 960,000 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 08:19 am |
N/A 2032-08-14 |
Magenta Therapeutics Inc. | MGTA | VASCONCELLES MICHAEL Director |
40,000 | $0 | 40,000 (Direct) |
View |